The success of copyright’s blockbuster initially drove a boom for the drug industry, but recent shifts present a complicated outlook for those considering a stake. Off-patent versions are eroding earnings, and https://finnianseqj270799.wizzardsblog.com/41129019/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-investment